These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 23144808

  • 21. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
    Silva FH, Leiria LO, Alexandre EC, Davel AP, Mónica FZ, De Nucci G, Antunes E.
    J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
    [Abstract] [Full Text] [Related]

  • 22. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M, Shimosato T, Iwasaki H, Imamura T, Okamura T.
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [Abstract] [Full Text] [Related]

  • 23. Aged Garlic Extract Inhibits Human Platelet Aggregation by Altering Intracellular Signaling and Platelet Shape Change.
    Rahman K, Lowe GM, Smith S.
    J Nutr; 2016 Feb; 146(2):410S-415S. PubMed ID: 26764324
    [Abstract] [Full Text] [Related]

  • 24. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
    Schäfer A, Flierl U, Kobsar A, Eigenthaler M, Ertl G, Bauersachs J.
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
    [Abstract] [Full Text] [Related]

  • 25. Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy.
    Mendes-Silverio CB, Lescano CH, Zaminelli T, Sollon C, Anhê GF, Antunes E, Mónica FZ.
    Biochem Pharmacol; 2018 Jun; 152():165-173. PubMed ID: 29605625
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats.
    Jabs A, Oelze M, Mikhed Y, Stamm P, Kröller-Schön S, Welschof P, Jansen T, Hausding M, Kopp M, Steven S, Schulz E, Stasch JP, Münzel T, Daiber A.
    Vascul Pharmacol; 2015 Aug; 71():181-91. PubMed ID: 25869522
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272.
    Hobbs AJ, Moncada S.
    Vascul Pharmacol; 2003 Oct; 40(3):149-54. PubMed ID: 13678646
    [Abstract] [Full Text] [Related]

  • 30. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
    Kempfert J, Behrends S.
    Platelets; 2003 Oct; 14(7-8):429-35. PubMed ID: 14713512
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
    Zhang G, Xiang B, Dong A, Skoda RC, Daugherty A, Smyth SS, Du X, Li Z.
    Blood; 2011 Sep 29; 118(13):3670-9. PubMed ID: 21803853
    [Abstract] [Full Text] [Related]

  • 34. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.
    Pankey EA, Bhartiya M, Badejo AM, Haider U, Stasch JP, Murthy SN, Nossaman BD, Kadowitz PJ.
    Am J Physiol Heart Circ Physiol; 2011 Mar 29; 300(3):H792-802. PubMed ID: 21217076
    [Abstract] [Full Text] [Related]

  • 35. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
    Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schröder H, Stahl E, Steinke W, Wunder F.
    Br J Pharmacol; 2002 Jul 29; 136(5):773-83. PubMed ID: 12086987
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs.
    Sömmer A, Sandner P, Behrends S.
    Biochem Pharmacol; 2018 Jan 29; 147():10-20. PubMed ID: 29155144
    [Abstract] [Full Text] [Related]

  • 39. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.